Expertise in
3
conditions

Dr. Laura F. Hutchins

Oncology | Hematology
4301 W Markham St # 508, 
Little Rock, AR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
3
conditions
4301 W Markham St # 508, 
Little Rock, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Laura Hutchins is an Oncologist and a Hematologist in Little Rock, Arkansas. Dr. Hutchins is highly rated in 3 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Melanoma, Inflammatory Breast Cancer, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 46 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in AR
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL

Locations

4301 W Markham St # 508, Little Rock, AR 72205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

In Vivo Real-time Detection of Circulating Melanoma Cells
In Vivo Real-time Detection of Circulating Melanoma Cells
Enrollment Status: Recruiting
Publish Date: July 16, 2025
A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Receiving Adjuvant Hormonal Therapy
A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Receiving Adjuvant Hormonal Therapy
Enrollment Status: Recruiting
Publish Date: April 29, 2025
Intervention Type: Drug
Study Drugs: Solifenacin, Clonidine
Study Phase: Phase 2
A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Drug
Study Drugs: Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 2
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Combined Phase I/II Feasibility-and-Efficacy Study of a Carbohydrate Mimotope-based Vaccine With MONTANIDE™ ISA 51 VG Combined With Neoadjuvant Chemotherapy
A Combined Phase I/II Feasibility-and-Efficacy Study of a Carbohydrate Mimotope-based Vaccine With MONTANIDE™ ISA 51 VG Combined With Neoadjuvant Chemotherapy
Enrollment Status: Completed
Publish Date: November 07, 2024
Intervention Type: Biological, Drug
Study Drug: Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
Study Phase: Phase 1/Phase 2
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

46 Total Publications

Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Database.
Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Database.
Journal: Clinical breast cancer
Published: January 26, 2024
Similar Doctors
Expertise in
41
conditions
Dr. Rangaswamy Govindarajan
Hematology | Oncology
Expertise in
41
conditions
Dr. Rangaswamy Govindarajan
Hematology | Oncology

University Of Arkansas For Medical Sciences

4301 W Markam St, 
Little Rock, AR 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances

Rangaswamy Govindarajan is a Hematologist and an Oncologist in Little Rock, Arkansas. Dr. Govindarajan is highly rated in 41 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy.

Expertise in
103
conditions
Dr. Balagopalan Nair
Hematology | Oncology
Expertise in
103
conditions
Dr. Balagopalan Nair
Hematology | Oncology

Central Arkansas Radiation Therapy Institute Inc

8901 Carti Way, 
Little Rock, AR 
 (2.9 miles away)
Languages Spoken:
English
See accepted insurances

Balagopalan Nair is a Hematologist and an Oncologist in Little Rock, Arkansas. Dr. Nair is highly rated in 103 conditions, according to our data. His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Thrombocytopenia, Polycythemia Vera, and Bone Marrow Aspiration.

Expertise in
90
conditions
Dr. Lawrence Mendelsohn
Hematology | Oncology
Expertise in
90
conditions
Dr. Lawrence Mendelsohn
Hematology | Oncology

Central Arkansas Radiation Therapy Institute Inc

8901 Carti Way, 
Little Rock, AR 
 (2.9 miles away)
501-906-3000
Languages Spoken:
English
See accepted insurances

Lawrence Mendelsohn is a Hematologist and an Oncologist in Little Rock, Arkansas. Dr. Mendelsohn is highly rated in 90 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hutchins's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile